StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
ESSA Pharma Inc.
NasdaqCM:EPIX
Sector
Industries
Location
Market Cap
USD 77.24 M
Share Price
USD 1.73
Avg Daily Volume
162,368
Change (1 day)
1.76%
Change (1 year)
-63.81%
Change (YTD)
-3.35%
ESSA Pharma Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2024: USD 0.00
ESSA Pharma Inc. Revenue is USD 0.00 for the Trailing 12 Months (TTM) ending December 31, 2024. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
ESSA Pharma Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 0.00.
-
ESSA Pharma Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 0.00.
-
ESSA Pharma Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 0.00.
-
ESSA Pharma Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 0.00.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Siemens Healthineers AG
USD 55.17
SHL.DE
-0.78
-1.39%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Siemens Healthineers AG
USD 55.17
SHL.DE
-0.78
-1.39%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%